398 related articles for article (PubMed ID: 26755492)
1. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
[TBL] [Abstract][Full Text] [Related]
2. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S
Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948
[TBL] [Abstract][Full Text] [Related]
3. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.
Poignant S; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
Antimicrob Agents Chemother; 2015 Dec; 60(3):1883-7. PubMed ID: 26666938
[TBL] [Abstract][Full Text] [Related]
5. Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
Ebrahimi F; Mózes J; Monostori J; Gorácz O; Fésűs A; Majoros L; Szarka K; Kardos G
Microbiol Immunol; 2016 May; 60(5):285-94. PubMed ID: 26959958
[TBL] [Abstract][Full Text] [Related]
6. Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
Prevel R; Boyer A; M'Zali F; Lasheras A; Zahar JR; Rogues AM; Gruson D
Crit Care; 2019 May; 23(1):170. PubMed ID: 31088542
[TBL] [Abstract][Full Text] [Related]
7. Quantifying risk of disease due to extended-spectrum β-lactamase producing Enterobacteriaceae in patients who are colonized at ICU admission.
Razazi K; Rosman J; Phan AD; Carteaux G; Decousser JW; Woerther PL; de Prost N; Brun-Buisson C; Mekontso Dessap A
J Infect; 2020 May; 80(5):504-510. PubMed ID: 32142931
[TBL] [Abstract][Full Text] [Related]
8. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
Detsis M; Karanika S; Mylonakis E
Crit Care Med; 2017 Apr; 45(4):705-714. PubMed ID: 28157141
[TBL] [Abstract][Full Text] [Related]
9. Extended spectrum beta-lactamase producing
Prevel R; Boyer A; M'Zali F; Cockenpot T; Lasheras A; Dubois V; Gruson D
Antimicrob Resist Infect Control; 2019; 8():112. PubMed ID: 31333839
[TBL] [Abstract][Full Text] [Related]
10. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
[TBL] [Abstract][Full Text] [Related]
11. Prior Carriage Predicts Intensive Care Unit Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Kallel H; Houcke S; Resiere D; Court T; Roncin C; Raad M; Nkontcho F; Demar M; Pujo J; Hommel D; Djossou F
Am J Trop Med Hyg; 2022 Jan; 106(2):525-531. PubMed ID: 35008044
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Carriage in Patients Admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand.
Kiddee A; Assawatheptawee K; Na-Udom A; Boonsawang P; Treebupachatsakul P; Walsh TR; Niumsup PR
Microb Drug Resist; 2019 Oct; 25(8):1182-1190. PubMed ID: 31140920
[TBL] [Abstract][Full Text] [Related]
13. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
[TBL] [Abstract][Full Text] [Related]
14. Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patients.
Luyt CE; Faure M; Bonnet I; Besset S; Huang F; Junot H; Hékimian G; Schmidt M; Bréchot N; Combes A; Aubry A; Mayaux J; Chastre J
Int J Antimicrob Agents; 2019 May; 53(5):547-552. PubMed ID: 30742956
[TBL] [Abstract][Full Text] [Related]
15. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.
Dautzenberg MJ; Wekesa AN; Gniadkowski M; Antoniadou A; Giamarellou H; Petrikkos GL; Skiada A; Brun-Buisson C; Bonten MJ; Derde LP;
Crit Care Med; 2015 Jun; 43(6):1170-7. PubMed ID: 25882764
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
[TBL] [Abstract][Full Text] [Related]
17. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
Pilmis B; Delory T; Groh M; Weiss E; Emirian A; Lecuyer H; Lesprit P; Zahar JR
Int J Infect Dis; 2015 Oct; 39():62-7. PubMed ID: 26327124
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
Razazi K; Derde LP; Verachten M; Legrand P; Lesprit P; Brun-Buisson C
Intensive Care Med; 2012 Nov; 38(11):1769-78. PubMed ID: 22893223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
